Selected research
Market Structure
Global Inhaled Nitric Oxide Therapy Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Inhaled Nitric Oxide Therapy Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Inhaled Nitric Oxide Therapy Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Inhaled Nitric Oxide Therapy Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Inhaled Nitric Oxide Therapy Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Inhaled Nitric Oxide Therapy Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Inhaled Nitric Oxide Therapy Solutions include Air Liquide, Linde and Mallinckrodt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Inhaled Nitric Oxide Therapy Solutions market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Inhaled Nitric Oxide Therapy Solutions and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Inhaled Nitric Oxide Therapy Solutions revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Inhaled Nitric Oxide Therapy Solutions market size, projected growth trends, production technologies, key applications, and end-use industries.
Inhaled Nitric Oxide Therapy Solutions Segment by Company
Air Liquide
Linde
Mallinckrodt
Inhaled Nitric Oxide Therapy Solutions Segment by Type
iNO Gas
Inhaled Nitric Oxide Delivery System
Inhaled Nitric Oxide Therapy Solutions Segment by Application
Hospitals
Other Healthcare System
Inhaled Nitric Oxide Therapy Solutions Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled Nitric Oxide Therapy Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inhaled Nitric Oxide Therapy Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled Nitric Oxide Therapy Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Inhaled Nitric Oxide Therapy Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Inhaled Nitric Oxide Therapy Solutions industry.
Chapter 3: Detailed analysis of Inhaled Nitric Oxide Therapy Solutions companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Inhaled Nitric Oxide Therapy Solutionsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- iNO Gas
- Inhaled Nitric Oxide Delivery System
Applications
- Hospitals
- Other Healthcare System
Companies covered
- Air Liquide
- Linde
- Mallinckrodt
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 iNO Gas
- 1.2.3 Inhaled Nitric Oxide Delivery System
- 1.3 Market Analysis by Application
- 1.3.1 Global Inhaled Nitric Oxide Therapy Solutions Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Other Healthcare System
- 1.4 Global Market Growth Prospects
- 1.5 Global Inhaled Nitric Oxide Therapy Solutions Growth Trends by Region
- 1.5.1 Global Inhaled Nitric Oxide Therapy Solutions Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Inhaled Nitric Oxide Therapy Solutions Market Size by Region (2021-2026)
- 1.5.3 Inhaled Nitric Oxide Therapy Solutions Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Inhaled Nitric Oxide Therapy Solutions Market Dynamics
- 2.1 Inhaled Nitric Oxide Therapy Solutions Industry Trends
- 2.2 Inhaled Nitric Oxide Therapy Solutions Industry Drivers
- 2.3 Inhaled Nitric Oxide Therapy Solutions Industry Opportunities and Challenges
- 2.4 Inhaled Nitric Oxide Therapy Solutions Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Inhaled Nitric Oxide Therapy Solutions Revenue by Company (2021-2026)
- 3.2 Global Inhaled Nitric Oxide Therapy Solutions Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Inhaled Nitric Oxide Therapy Solutions Key Company Head office and Area Served
- 3.4 Global Inhaled Nitric Oxide Therapy Solutions Company, Product Type & Application
- 3.5 Global Inhaled Nitric Oxide Therapy Solutions Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Inhaled Nitric Oxide Therapy Solutions Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Inhaled Nitric Oxide Therapy Solutions Players Market Share by Revenue in 2025
- 3.6.3 2025 Inhaled Nitric Oxide Therapy Solutions Tier 1, Tier 2, and Tier 3
4 Inhaled Nitric Oxide Therapy Solutions Market by Type
- 4.1 Global Inhaled Nitric Oxide Therapy Solutions Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Inhaled Nitric Oxide Therapy Solutions Market Size by Type (2021-2032)
- 4.3 Global Inhaled Nitric Oxide Therapy Solutions Market Size Share by Type (2021-2032)
5 Inhaled Nitric Oxide Therapy Solutions Market by Application
- 5.1 Global Inhaled Nitric Oxide Therapy Solutions Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Inhaled Nitric Oxide Therapy Solutions Market Size by Application (2021-2032)
- 5.3 Global Inhaled Nitric Oxide Therapy Solutions Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Air Liquide
- 6.1.1 Air Liquide Company Information
- 6.1.2 Air Liquide Business Overview
- 6.1.3 Air Liquide Inhaled Nitric Oxide Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Air Liquide Inhaled Nitric Oxide Therapy Solutions Product Portfolio
- 6.1.5 Air Liquide Recent Developments
- 6.2 Linde
- 6.2.1 Linde Company Information
- 6.2.2 Linde Business Overview
- 6.2.3 Linde Inhaled Nitric Oxide Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Linde Inhaled Nitric Oxide Therapy Solutions Product Portfolio
- 6.2.5 Linde Recent Developments
- 6.3 Mallinckrodt
- 6.3.1 Mallinckrodt Company Information
- 6.3.2 Mallinckrodt Business Overview
- 6.3.3 Mallinckrodt Inhaled Nitric Oxide Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Mallinckrodt Inhaled Nitric Oxide Therapy Solutions Product Portfolio
- 6.3.5 Mallinckrodt Recent Developments
7 North America
- 7.1 North America Inhaled Nitric Oxide Therapy Solutions Market Size (2021-2032)
- 7.2 North America Inhaled Nitric Oxide Therapy Solutions Market Size by Type
- 7.2.1 North America Inhaled Nitric Oxide Therapy Solutions Market Size by Type (2021-2026)
- 7.2.2 North America Inhaled Nitric Oxide Therapy Solutions Market Size by Type (2027-2032)
- 7.2.3 North America Inhaled Nitric Oxide Therapy Solutions Market Share by Type (2021-2032)
- 7.3 North America Inhaled Nitric Oxide Therapy Solutions Market Size by Application
- 7.3.1 North America Inhaled Nitric Oxide Therapy Solutions Market Size by Application (2021-2026)
- 7.3.2 North America Inhaled Nitric Oxide Therapy Solutions Market Size by Application (2027-2032)
- 7.3.3 North America Inhaled Nitric Oxide Therapy Solutions Market Share by Application (2021-2032)
- 7.4 North America Inhaled Nitric Oxide Therapy Solutions Market Size by Country
- 7.4.1 North America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2021-2026)
- 7.4.3 North America Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2027-2032)
- 7.4.4 North America Inhaled Nitric Oxide Therapy Solutions Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Inhaled Nitric Oxide Therapy Solutions Market Size (2021-2032)
- 8.2 Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Type
- 8.2.1 Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Type (2021-2026)
- 8.2.2 Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Type (2027-2032)
- 8.2.3 Europe Inhaled Nitric Oxide Therapy Solutions Market Share by Type (2021-2032)
- 8.3 Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Application
- 8.3.1 Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Application (2021-2026)
- 8.3.2 Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Application (2027-2032)
- 8.3.3 Europe Inhaled Nitric Oxide Therapy Solutions Market Share by Application (2021-2032)
- 8.4 Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Country
- 8.4.1 Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2021-2026)
- 8.4.3 Europe Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2027-2032)
- 8.4.4 Europe Inhaled Nitric Oxide Therapy Solutions Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Inhaled Nitric Oxide Therapy Solutions Market Size (2021-2032)
- 9.2 China Inhaled Nitric Oxide Therapy Solutions Market Size by Type
- 9.2.1 China Inhaled Nitric Oxide Therapy Solutions Market Size by Type (2021-2026)
- 9.2.2 China Inhaled Nitric Oxide Therapy Solutions Market Size by Type (2027-2032)
- 9.2.3 China Inhaled Nitric Oxide Therapy Solutions Market Share by Type (2021-2032)
- 9.3 China Inhaled Nitric Oxide Therapy Solutions Market Size by Application
- 9.3.1 China Inhaled Nitric Oxide Therapy Solutions Market Size by Application (2021-2026)
- 9.3.2 China Inhaled Nitric Oxide Therapy Solutions Market Size by Application (2027-2032)
- 9.3.3 China Inhaled Nitric Oxide Therapy Solutions Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Inhaled Nitric Oxide Therapy Solutions Market Size (2021-2032)
- 10.2 Asia Inhaled Nitric Oxide Therapy Solutions Market Size by Type
- 10.2.1 Asia Inhaled Nitric Oxide Therapy Solutions Market Size by Type (2021-2026)
- 10.2.2 Asia Inhaled Nitric Oxide Therapy Solutions Market Size by Type (2027-2032)
- 10.2.3 Asia Inhaled Nitric Oxide Therapy Solutions Market Share by Type (2021-2032)
- 10.3 Asia Inhaled Nitric Oxide Therapy Solutions Market Size by Application
- 10.3.1 Asia Inhaled Nitric Oxide Therapy Solutions Market Size by Application (2021-2026)
- 10.3.2 Asia Inhaled Nitric Oxide Therapy Solutions Market Size by Application (2027-2032)
- 10.3.3 Asia Inhaled Nitric Oxide Therapy Solutions Market Share by Application (2021-2032)
- 10.4 Asia Inhaled Nitric Oxide Therapy Solutions Market Size by Country
- 10.4.1 Asia Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2021-2026)
- 10.4.3 Asia Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2027-2032)
- 10.4.4 Asia Inhaled Nitric Oxide Therapy Solutions Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Type
- 11.2.1 South America, Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Application
- 11.3.1 South America, Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Country
- 11.4.1 South America, Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst